GB9917975D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9917975D0
GB9917975D0 GBGB9917975.6A GB9917975A GB9917975D0 GB 9917975 D0 GB9917975 D0 GB 9917975D0 GB 9917975 A GB9917975 A GB 9917975A GB 9917975 D0 GB9917975 D0 GB 9917975D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9917975.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9917975.6A priority Critical patent/GB9917975D0/en
Publication of GB9917975D0 publication Critical patent/GB9917975D0/en
Priority to CA002380518A priority patent/CA2380518A1/en
Priority to EP00958311A priority patent/EP1216301A2/en
Priority to AU69880/00A priority patent/AU6988000A/en
Priority to PCT/EP2000/007296 priority patent/WO2001009333A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
GBGB9917975.6A 1999-07-30 1999-07-30 Novel compounds Ceased GB9917975D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9917975.6A GB9917975D0 (en) 1999-07-30 1999-07-30 Novel compounds
CA002380518A CA2380518A1 (en) 1999-07-30 2000-07-27 Novel compounds
EP00958311A EP1216301A2 (en) 1999-07-30 2000-07-27 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
AU69880/00A AU6988000A (en) 1999-07-30 2000-07-27 Novel compounds
PCT/EP2000/007296 WO2001009333A2 (en) 1999-07-30 2000-07-27 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9917975.6A GB9917975D0 (en) 1999-07-30 1999-07-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB9917975D0 true GB9917975D0 (en) 1999-09-29

Family

ID=10858276

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9917975.6A Ceased GB9917975D0 (en) 1999-07-30 1999-07-30 Novel compounds

Country Status (5)

Country Link
EP (1) EP1216301A2 (en)
AU (1) AU6988000A (en)
CA (1) CA2380518A1 (en)
GB (1) GB9917975D0 (en)
WO (1) WO2001009333A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100594239C (en) 2002-08-12 2010-03-17 金克克国际有限公司 Mutant E. coli APPA phytase enzymes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2218731A1 (en) * 1997-11-28 2010-08-18 Merck Serono Biodevelopment Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Also Published As

Publication number Publication date
EP1216301A2 (en) 2002-06-26
CA2380518A1 (en) 2001-02-08
WO2001009333A3 (en) 2001-07-05
AU6988000A (en) 2001-02-19
WO2001009333A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
GB9902084D0 (en) Novel compounds
GB9902697D0 (en) Novel compounds
EG24063A (en) Novel compounds
GB9921691D0 (en) Novel compounds
GB9901256D0 (en) Novel compounds
GB9902937D0 (en) Novel compounds
GB9902880D0 (en) Novel compounds
GB9917975D0 (en) Novel compounds
GB9902070D0 (en) Novel compounds
GB9902009D0 (en) Novel compounds
GB9901946D0 (en) Novel compounds
GB9902086D0 (en) Novel compounds
GB9902078D0 (en) Novel compounds
GB9901368D0 (en) Novel compounds
GB9902077D0 (en) Novel compounds
GB9902074D0 (en) Novel compounds
GB9902879D0 (en) Novel compounds
GB9928278D0 (en) Novel compounds
GB9902169D0 (en) Novel compounds
GB9921692D0 (en) Novel compounds
GB9902164D0 (en) Novel compounds
GB9902657D0 (en) Novel compounds
GB9902165D0 (en) Novel compounds
GB9902936D0 (en) Novel compounds
GB9902090D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)